Connecting Advanced Therapies to Patients across Canada

By Simon Ellison |

In a short seminar, titled Connecting Advanced Therapies to Patients across Canada, Simon Ellison, Cell and Gene Therapy Service Director, touches upon industry trends, logistics by design, four critical shipments across advanced therapies, as well as critical logistics attributes.

Experiences and solutions to supply chain and logistics challenges for the CGT industry were shared alongside key considerations for the first and last 100 meters to get a treatment to the clinic.

The seminar was hosted by CCRM and CellCAN. 

The Supply Chain & Logistics for Cell & Gene Therapies (CGT) Seminar took place on January 20, 2020, in Toronto, Canada.

To access the 20 minute seminar visit: Commercializing Living Therapies.

About the Author

A portrait of Simon Eliison.

Simon Ellison

Cell and Gene Therapy Service Director 
World Courier
Simon is the Cell and Gene Therapy Service Director at World Courier.  His role is to develop a portfolio of global logistic and supporting service strategies that take the advanced therapy industry forwards. Whilst at the Cell and Gene Therapy Catapult he identified the need for, and built the Seamless Freight portfolio.  He also helped develop the commercial operating model for the Catapult Manufacturing Centre that resulted in the first collaborators entering, and the start of a cluster forming around this unique facility. Prior to this Simon was the Head of Commercial at NHS Blood and Transplant (NHSBT) where he merged the needs of the industry with NHSBTs manufacturing and supply chain capability. This enabled multiple UK and international organisations to move their therapies forwards.
View Bio